Stockreport

Bio-Rad outlines 2026 margin expansion and 0.5%-1.5% revenue growth guidance amid operational improvements [Seeking Alpha]

Bio-Rad Laboratories, Inc. Class B  (BIO.B) 
PDF Jonathan DiVincenzo, President & COO, stated that Bio-Rad delivered results within revised guidance for both revenue and operating margin, but "gross margin did not mee [Read more]